EDGAR Filing Documents for 0000950170-24-040337

Form 8-K - Current report:

SEC Accession No. 0000950170-24-040337

Filing Date

2024-04-02

Accepted

2024-04-02 17:07:54

Documents

Period of Report

2024-04-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	srzn-20240401.htm iXBRL	8-K	70363
2	EX-10.1	srzn-ex10_1.htm	EX-10.1	381536
3	EX-10.2	srzn-ex10_2.htm	EX-10.2	136597
4	EX-10.3	srzn-ex10_3.htm	EX-10.3	147907
5	EX-10.4	srzn-ex10_4.htm	EX-10.4	149281
6	EX-10.5	srzn-ex10_5.htm	EX-10.5	148243
7	EX-10.6	srzn-ex10_6.htm	EX-10.6	148526
8	EX-10.7	srzn-ex10_7.htm	EX-10.7	220250
	Complete submission text file	0000950170-24-040337.txt		1774707

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT	srzn-20240401.xsd	EX-101.SCH	46157
22	EXTRACTED XBRL INSTANCE DOCUMENT	srzn-20240401_htm.xml	XML	6600

Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820

Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 24815439
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)